Lilly granted US TRO to halt at-risk launch of generic Evista
This article was originally published in Scrip
Executive Summary
Judge Sarah Evans Barker with the US District Court for the Southern District of Indiana has granted Lilly's request for a temporary restraining order to halt the launch of Teva Pharmaceutical Industries' generic version of Evista (raloxifene HCl) because of a patent infringement lawsuit.